Partner sirolimus eluting coronary stent clinical analysis of complex lesions.docVIP

Partner sirolimus eluting coronary stent clinical analysis of complex lesions.doc

  1. 1、本文档共11页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Partner sirolimus eluting coronary stent clinical analysis of complex lesions

 PAGE \* MERGEFORMAT 11 Partner sirolimus eluting coronary stent clinical analysis of complex lesions Of: Ma, Official strong, Liji Wu, Chen Peng, Lin Cong, Ji Kang Ting, Yang Penglin, Tang darting [Abstract] Objective: To investigate the Domestic Partner sirolimus-eluting stents in complex coronary lesions in patients with the efficacy and safety applications. Methods: A retrospective hospital from November 2006 to April 2008 received home Ruxi Luo Secretary Mo coronary drug-eluting stent for complex lesions in patients with 216 cases, divided according to type of implanted stent Partner Group, Cypher group. Comparison of 2 groups of coronary lesions and stent implantation conditions, adverse cardiac events (majoradverse cardiovascular events, MACE ) the incidence and event-free survival. Results: Baseline data matching between the two groups, Partner group is relatively more complex coronary lesions, more chronic total occlusion, long lesion, C-type lesions, the number of multi-vessel disease than Cypher group. Partner group into two or more stents are 40%, Cypher stent group into two or more 15.5% difference between the groups was significant. The median follow-up time, 413d, the upper and lower interquartile range 287 d to 569 d.MACE rate: Partner group 6.0%, Cypher group 7.8% (Pgt; 0.05). There was no event-free survival were 94.0% and 92.2%, the difference was not statistically significant. Conclusion: Partner stents in coronary heart disease complex lesions is safe and effective, the clinical results and import similar to sirolimus-eluting stent. [Keywords:] Coronary artery disease; sirolimus; drug-eluting stent; adverse cardiac events Sirolimus-eluting stents can significantly reduce the incidence of restenosis rate and target lesion revascularization rate applied in the clinical treatment of coronary intervention was a great benefit. But imports sirolimus washout Cypher stent off expensive hindered its widespread application. Domestic Partn

文档评论(0)

hhuiws1482 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档